Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 2CNS 2NET 1Head & Neck 1

Conditions

Thyroid Neoplasms 6Thyroid Cancer, Papillary 3Carcinoma, Medullary 3Adenocarcinoma, Follicular 3Thyroid Diseases 2Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Melanoma 2Triple Negative Breast Neoplasms 1Thyroid cancer, medullary 1Thyroid cancer, follicular 1Thyroid Carcinoma, Anaplastic 1Stomach Neoplasms 1Salivary Gland Neoplasms 1Refractory Differentiated Thyroid Gland Carcinoma 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neuroendocrine Tumors 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Locally Advanced Thyroid Gland Carcinoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Squamous Cell Cancer 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Differentiated Thyroid Cancer (DTC) 1Colorectal Neoplasms 1

Interventions

Specimen Handling 2Radiotherapy 2Magnetic Resonance Spectroscopy 2tipifarnib 1pentetreotide 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1fostamatinib 1fluorodopa F 18 1fludarabine phosphate 1cabozantinib 1atezolizumab 1Tamoxifen 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Octreotide 1Nivolumab 1Molecular Diagnostic Techniques 1Ipilimumab 1Interleukin-13 1Indinavir 1Immunotherapy 1Genetic Testing 1Fluorodeoxyglucose F18 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Cryosurgery 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pheochromocytoma × cabozantinib × Head & Neck × Clear all
NCT04400474 2025-06-19

CABATEN

Grupo Espanol de Tumores Neuroendocrinos

Phase 2 Completed
93 enrolled 17 charts
CNSEndocrineHead & NeckNET

Adenocarcinoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡